Why Interpretation Requires Care
A joint model can connect a repeatedly measured biomarker to the cause-specific hazard of an event. That connection can improve prognosis: among people with the same modeled covariates and latent health characteristics, a higher biomarker value may signal a higher instantaneous rate of a particular event. But a predictive association is not automatically the effect of changing the biomarker. The biomarker may be a consequence or indicator of underlying health, and that underlying health may also affect the event process.
This distinction matters especially in competing-risks settings. A cause-specific hazard describes the instantaneous event rate for one cause among people who have not yet experienced any competing event. It is conditional on remaining event-free up to that time. A coefficient in a joint model therefore has a specific conditional meaning; it is not, by itself, a comparison of event probabilities under interventions.
What a Cause-Specific Association Coefficient Says
For illustration, let \(m_i(t)\) denote the modeled underlying longitudinal marker value for individual \(i\), and let \(b_i\) denote that individual’s shared random effects. For event cause \(k\), consider the current-value association model
Here \(\lambda_{0k}(t)\) is the cause-specific baseline hazard, \(w_i\) is a vector of event-process covariates, and \(\alpha_k\) is the cause-specific current-value association parameter. The model states that, at a given time, the cause-\(k\) hazard is compared among individuals with the same modeled covariates and random effects. It also presumes the specified hazard form is adequate, the relevant event causes and times are correctly recorded, and the longitudinal and event processes are represented by the chosen joint model.
For a difference \(\Delta\) in the modeled marker value, the conditional cause-specific hazard ratio is \(\exp(\alpha_k\Delta)\). The unit of \(\alpha_k\) is the reciprocal of the marker’s unit; the hazard ratio is dimensionless. This is an association on the hazard scale, conditional on the model. It does not say that intervening to raise the marker by \(\Delta\) would multiply a person’s hazard by that ratio.
Worked Example: Translating a Coefficient Into a Conditional Association
Suppose, hypothetically, a fitted cause-specific joint model gives \(\hat{\alpha}_1=0.4055\) per marker unit for event cause 1. Compare two otherwise model-matched individuals whose underlying marker values differ by 2 units.
The conditional hazard ratio is
Thus, under this model, the individual with the marker value 2 units higher has an estimated cause-1 hazard about 2.25 times as large at the time being considered, conditional on the modeled covariates and shared random effects and while event-free. This is a prognostic association. It does not establish that changing the marker by 2 units would cause the hazard to change by this factor.
The interpretation depends on using the underlying marker value \(m_i(t)\), not an arbitrary noisy measurement at one visit. It also depends on the event-specific model: the result concerns cause 1, not all events combined.
How Shared Latent Health Can Create Association
A shared random effect can represent persistent individual differences that influence both the longitudinal trajectory and event risk. For instance, an unobserved health state may lower a biomarker and raise the hazard. In that case, the marker and event process are statistically linked because they share a cause. Even if the marker itself has no effect on the event, the observed marker can still be prognostic.
A joint model represents dependence through its specified shared effects and association structure. That is valuable for describing the data and accounting for dependence between repeated measurements and event times. But including a random effect does not guarantee that every common cause has been captured, that its distribution is correct, or that the marker is unconfounded. Moreover, conditioning on a latent random effect in a model is not equivalent to a randomized intervention on the marker.
Worked Example: An Association With No Marker Effect
Consider a hypothetical population with a binary latent health state \(U\). Individuals with \(U=1\) have a cause-specific event rate of \(0.040\) events per person-year; those with \(U=0\) have a rate of \(0.020\) events per person-year. Suppose the biomarker has no effect on either rate: conditional on \(U\), the rate does not depend on the marker. However, poor latent health is more common among people with a high marker value:
- Among people with a high marker, \(P(U=1\mid M=1)=0.80\).
- Among people with a low marker, \(P(U=1\mid M=0)=0.20\).
At the start of follow-up, the high-marker group’s average cause-specific rate is
For the low-marker group it is
The ratio of these initial average rates is \(0.036/0.024=1.50\). The high-marker group therefore has a 1.50-fold higher initial average rate, even though the marker has no effect within either latent-health group. The association arises because the groups differ in their distribution of \(U\). This simple mixture calculation is not a complete longitudinal joint model; it demonstrates why an observed association alone cannot settle the causal question.
Why Marginal and Conditional Associations Can Differ
The model’s conditional hazard ratio need not equal a population-average contrast. To see the issue, suppose individuals have different latent hazards. As time passes, those at higher risk tend to experience the event earlier. The people who remain event-free in a group therefore become a selected subset. A marginal cause-specific hazard averages over the latent characteristics of those still at risk, and that composition can change over time.
For a latent state \(U\), the marginal cause-specific hazard among those still event-free can be written as an average of individual hazards weighted by the distribution of \(U\) among survivors:
The weights \(P(U=u\mid M,T\ge t)\) need not equal their baseline values \(P(U=u\mid M)\). Thus, even when a conditional model has a stable coefficient, the corresponding marginal association may vary with time. In competing risks, experiencing another cause also removes a person from the risk set for cause \(k\), so the cause-specific hazard is not itself the cumulative probability of cause \(k\).
This distinction is one reason to state exactly what a coefficient estimates. A cause-specific joint-model coefficient is a conditional parameter in the specified model. A cumulative incidence is a population probability that depends on the cause-specific hazards together. Neither should be casually substituted for the other.
Worked Example: Reading an Estimate and Its Uncertainty Without Overclaiming
Suppose, hypothetically, a joint model estimates \(\hat{\alpha}_2=0.2624\) per marker unit with \(SE(\hat{\alpha}_2)=0.1200\). For a 1-unit marker contrast, the estimated hazard ratio for cause 2 is
A Wald 95% confidence interval for the log coefficient is
Exponentiating the endpoints gives a 95% interval for the conditional hazard ratio:
Under the model and its large-sample approximation, this interval is compatible with conditional cause-2 hazard ratios from about 1.03 to 1.65 per marker unit. It is not a 95% probability statement about the fixed parameter, and it does not convert the association into a causal effect. The interval also does not account for model misspecification merely because it is numerically precise.
A Short Derivation and Its Interpretation
The hazard ratio formula follows directly by comparing two conditional hazards at the same time, for individuals with the same \(w_i\) and \(b_i\), but marker values differing by \(\Delta\). Denote those marker values by \(m\) and \(m+\Delta\). Then
The baseline hazard and covariate term cancel, yielding a conditional association on the hazard scale. This algebra establishes the model-based comparison; it does not establish that \(m\) can be changed independently of the factors that determine it. A causal interpretation would require a well-defined intervention and additional identification assumptions, such as consistency, exchangeability given measured pre-intervention covariates, and positivity for the intervention levels being compared. It would also require a method that targets the causal estimand of interest.
For a biomarker that is a manifestation of underlying disease, “set the biomarker to a higher value” may not even define a single intervention: different treatments could change the marker through different pathways and have different effects on the event. In that setting, a biomarker coefficient can still have prognostic value while lacking a straightforward intervention interpretation.
Diagnostics, Alternatives, and Limitations
Interpretation is only as credible as the model and data that support it. Check whether the longitudinal trajectory and residual variation describe the repeated measurements adequately, whether the chosen random-effects distribution is plausible, and whether the event-time specification fits each cause. Also examine whether estimates are stable under reasonable alternative association structures and baseline-hazard choices. Sparse events for a cause can make its association estimate unstable; a narrow-looking numerical output should not be taken as proof that the latent structure is well identified.
A useful diagnostic question is whether conclusions change materially when plausible unmeasured-health dependence or random-effects assumptions are varied. If they do, report that sensitivity rather than presenting one fitted coefficient as definitive. A joint model cannot diagnose every unmeasured common cause from the observed data alone. Nor does good predictive performance validate a causal interpretation.
| Approach | Primary interpretation | What it does not establish by itself |
|---|---|---|
| Cause-specific joint-model coefficient | Conditional prognostic association for a specified event cause, given modeled quantities | The effect of intervening on the marker |
| Unadjusted marker–event comparison | Observed association in the compared groups | Control of shared latent health or other confounding |
| Causal analysis using a defined intervention and justified assumptions | A contrast in outcomes under specified intervention strategies | Validity without credible design, measurement and identification assumptions |
The main alternative depends on the question. For prediction, a validated joint model may be appropriate, with performance assessed in the intended population. For an intervention question, the analyst must define the intervention and target outcome first, then use a causal design and assumptions suited to that question. Simply changing the label on \(\alpha_k\), or adding more covariates without justification, does not change the estimand.
Common Pitfall
Correction: A positive coefficient indicates a positive conditional association under the specified joint model. Shared random effects represent modeled dependence, but do not prove that all common causes are controlled or define a manipulable marker intervention. Use causal language only when a causal estimand and its identification assumptions are justified.
A related mistake is to describe a cause-specific hazard ratio as a ratio of cumulative event probabilities. A cause-specific hazard concerns an instantaneous rate among people still event-free; cumulative incidence is a probability over time and reflects competing events as well. State the scale and risk set whenever reporting an association.
Check Your Understanding
Answer each question, then compare your reasoning with the solutions.
- A fitted current-value coefficient for a cause-specific hazard is \(0.20\) per biomarker unit. What is the model-implied conditional hazard ratio for a 3-unit contrast, and what does it mean?
- In a hypothetical mixture, the event rates are \(0.030\) per person-year for latent-health state \(U=1\) and \(0.010\) for \(U=0\). If \(P(U=1\mid M=1)=0.75\) and \(P(U=1\mid M=0)=0.25\), calculate the ratio of the groups’ initial average rates. Does it prove a marker effect?
- Why can a conditional cause-specific hazard ratio differ from a marginal hazard comparison over follow-up?
- Name two reasons a shared random effect does not, by itself, justify a causal interpretation of the biomarker coefficient.
Solutions. (1) The ratio is \(\exp(0.20\times3)=\exp(0.60)\approx1.822\). It is an estimated 1.822-fold cause-specific hazard association for the 3-unit contrast, conditional on the modeled quantities and event-free status; it is not an intervention effect. (2) The \(M=1\) rate is \(0.75(0.030)+0.25(0.010)=0.025\) events per person-year. The \(M=0\) rate is \(0.25(0.030)+0.75(0.010)=0.015\). Their ratio is \(0.025/0.015=1.667\). This observed difference can arise from the unequal latent-health distributions and does not prove a marker effect. (3) The latent composition of the event-free risk set can change over time as higher-risk individuals experience an event; marginal hazards average over that changing composition. (4) The random-effects distribution or dependence structure may be misspecified, and other common causes may remain unmodeled. Also, a modeled conditional association does not define a well-specified intervention on the marker.